Cytotherapy
Overview
Cytotherapy is a peer-reviewed journal dedicated to advancing the field of cell-based therapies. It publishes cutting-edge research on the use of cells, including stem cells and immune cells, for the treatment of various diseases and injuries. With a focus on clinical applications, the journal provides a platform for scientists, clinicians, and industry professionals to share their findings and insights, ultimately contributing to the development of innovative cell-based therapies.
Details
Details
Abbr.
Cytotherapy
Publisher
Elsevier
Start
1999
End
Continuing
Frequency
Eight no. a year, 2007-
p-ISSN
1465-3249
e-ISSN
1477-2566
Country
United Kingdom
Language
English
Specialties
Pharmacology
Cell Biology
Cell Biology
Metrics
Metrics
h-index / Ranks: 2861
105
SJR / Ranks: 3305
1084
CiteScore / Ranks: 2478
7.60
JIF / Ranks: 1882
4.5
Recent Articles
1.
Cober N, Chaudhary K, Deng Y, Lee C, Rowe K, Abdelwahab H, et al.
Cytotherapy
. 2025 Mar;
PMID: 40088252
Pulmonary arterial hypertension (PAH) is triggered by pulmonary vascular endothelial cell apoptosis and microvascular loss. Therefore, therapies that can regenerate lost vasculature may offer therapeutic benefit. Endothelial colony-forming cells (ECFCs)...
2.
Lin G, Tao M, Sun H, Deng X, Zhang L, Sun G, et al.
Cytotherapy
. 2025 Mar;
PMID: 40072405
Asthma, a prevalent allergic disease affecting approximately 300 million individuals globally, remains a significant public health challenge. Mesenchymal stromal cells (MSCs) and hepatocyte growth factor (HGF), both recognized for their...
3.
Kunkanjanawan H, Somredngan S, Kunkanjanawan T, Wongtrakoongate P, Wongsakmanee W, Khemarangsan V, et al.
Cytotherapy
. 2025 Mar;
PMID: 40057889
Growing research in the immunotherapy field has shed light on the adoptive cell transfer efficacy of ex vivo expanded natural killer (NK) cells in cancer treatment. In accordance with the...
4.
Hwang W, Muzammil E
Cytotherapy
. 2025 Mar;
PMID: 40047735
2024 marked a transformative phase for cell and gene therapy (CGT) with significant advancements in scientific innovation, regulatory approvals and commercialization milestones. This review highlights key developments in CGT, including...
5.
Ping W, Xu X, Jiang Y, Yang R, Xu L
Cytotherapy
. 2025 Mar;
PMID: 40047734
Approximately 25% of patients with acute kidney injury (AKI) progress to chronic kidney disease, driven by the transition of renal tubular epithelial cells from epithelial to mesenchymal cells. Recent studies...
6.
Maryamchik E, Ikonomou L, Roxland B, Grignon F, Levine B, Grilley B
Cytotherapy
. 2025 Mar;
PMID: 40029229
This position paper reviews the Expanded Access pathway for cell and gene therapies, examining its critical role at the nexus of patient need, regulatory frameworks, and scientific advancement. Spearheaded by...
7.
Costa M, Costa C, Matos L, Sebastiao M, Duarte N, Costa M, et al.
Cytotherapy
. 2025 Feb;
PMID: 40019461
Background Aims: Autologous cell therapies using chimeric antigen receptor (CAR) T cells have shown significant clinical success in hematologic cancers. However, current production platforms face challenges in scaling up to...
8.
Sharma Y, Mohanty S
Cytotherapy
. 2025 Feb;
PMID: 39985543
In the intricate landscape of cellular communication, small extracellular vesicles (sEVs) originating from endosomes play crucial roles as mediators and have garnered significant attention in theranostics. Our understanding of sEV...
9.
Cytotherapy
. 2025 Feb;
PMID: 39985542
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can...
10.
Takahashi J
Cytotherapy
. 2025 Feb;
PMID: 39969437
The advancement of induced pluripotent stem cell (iPSC) technology has revolutionized regenerative medicine, enabling breakthroughs in disease modeling, drug discovery, and cell replacement therapies. This review examines the progression of...